In humans, single nucleotide polymorphisms in MFSD2A and changes in MFSD2A expression levels have been implicated in several severe neurological disorders including autosomal recessive primary microcephaly6–11, intracranial haemorrhage and Alzheimer’s disease12. Here, MFSD2A is linked to nervous system disorder.